|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 232.86 USD | +0.59% |
|
+4.68% | +1.91% |
| 02-18 | Mubadala Investment Co PJSC reports share stake in Pfizer, AbbVie, dissolves in Merck, Dell | RE |
| 02-17 | HSBC Adjusts Price Target on AbbVie to $275 From $265, Maintains Buy Rating | MT |
| Capitalization | 412B 348B 318B 304B 562B 37,305B 583B 3,707B 1,468B 17,994B 1,544B 1,512B 63,218B | P/E ratio 2025 |
96.8x | P/E ratio 2026 * | 24.6x |
|---|---|---|---|---|---|
| Enterprise value | 468B 396B 361B 346B 639B 42,420B 663B 4,215B 1,669B 20,461B 1,755B 1,719B 71,886B | EV / Sales 2025 |
6.6x | EV / Sales 2026 * | 6.87x |
| Free-Float |
96.39% | Yield 2025 * |
2.81% | Yield 2026 * | 2.98% |
Last Transcript: AbbVie Inc.
| 1 day | +0.59% | ||
| 1 week | +4.68% | ||
| Current month | +4.42% | ||
| 1 month | +8.64% | ||
| 3 months | -0.49% | ||
| 6 months | +12.66% | ||
| Current year | +1.91% |
| 1 week | 220.91 | 235.25 | |
| 1 month | 204.27 | 235.25 | |
| Current year | 204.27 | 237.04 | |
| 1 year | 164.39 | 244.81 | |
| 3 years | 130.96 | 244.81 | |
| 5 years | 102.05 | 244.81 | |
| 10 years | 53.74 | 244.81 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Michael
CEO | Chief Executive Officer | 55 | 01/07/2024 |
Scott Reents
DFI | Director of Finance/CFO | 59 | 23/06/2022 |
Roopal Thakkar
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2003 |
| Director | Title | Age | Since |
|---|---|---|---|
Roxanne Austin
BRD | Director/Board Member | 65 | 01/01/2013 |
William Burnside
BRD | Director/Board Member | 74 | 01/01/2013 |
Edward Rapp
BRD | Director/Board Member | 68 | 01/01/2013 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.59% | +4.68% | +20.73% | +53.90% | 412B | ||
| -0.38% | +1.08% | +22.72% | +215.48% | 926B | ||
| -0.05% | +2.09% | +55.83% | +51.71% | 586B | ||
| +0.14% | +3.48% | +25.19% | +31.83% | 382B | ||
| +0.39% | +5.51% | +32.63% | +35.48% | 326B | ||
| +0.42% | +4.73% | +34.05% | +61.43% | 317B | ||
| +0.13% | +3.77% | +46.45% | +11.00% | 302B | ||
| +0.23% | +1.19% | -47.13% | -36.90% | 218B | ||
| +1.13% | +2.39% | +28.23% | +55.22% | 201B | ||
| +0.19% | +5.46% | +49.18% | +83.19% | 193B | ||
| Average | +0.28% | +3.39% | +26.79% | +56.24% | 386.18B | |
| Weighted average by Cap. | +0.14% | +3.07% | +29.06% | +82.23% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 60.96B 51.54B 47.07B 45.06B 83.25B 5,525B 86.3B 549B 217B 2,665B 229B 224B 9,364B | 67.08B 56.71B 51.79B 49.58B 91.6B 6,080B 94.96B 604B 239B 2,933B 252B 246B 10,304B |
| Net income | 7.42B 6.28B 5.73B 5.49B 10.14B 673B 10.51B 66.88B 26.48B 325B 27.85B 27.27B 1,141B | 17.37B 14.69B 13.41B 12.84B 23.72B 1,575B 24.59B 156B 61.96B 759B 65.15B 63.8B 2,668B |
| Net Debt | 56.43B 47.71B 43.57B 41.71B 77.06B 5,115B 79.89B 508B 201B 2,467B 212B 207B 8,668B | 49.35B 41.72B 38.1B 36.48B 67.39B 4,473B 69.86B 444B 176B 2,158B 185B 181B 7,580B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/02/26 | 232.86 $ | +0.59% | 7,336,770 |
| 13/02/26 | 231.50 $ | +1.76% | 8,252,480 |
| 12/02/26 | 227.50 $ | +2.99% | 8,712,013 |
| 11/02/26 | 220.89 $ | -0.70% | 8,072,636 |
| 10/02/26 | 222.44 $ | -0.37% | 6,044,475 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ABBV Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
















